The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
Currently, research on the effect of thiamine administration during transcatheter closure on the structure and function of the left ventricle by examining levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in children with left to right shunt congenital heart disease has never been carried out in Indonesia, so it is necessary carried out this research. This research was carried out by administering 100 mg of thiamine once per day to patients post transcatheter closure for 28 days. The parameters assessed were MMP-9, TIMP-1, and echocardiography to assess the structure and function of the left ventricle in CHD patients with left to right shunt lesions.
- EligibilityCriteria: Inclusion Criteria:  Patients aged 6 months - 18 years. Patients diagnosed with left to right shunt lesion CHD with heart failure based on ROSS or NYHA criteria. Patients who will undergo intervention with transcatheter closure.  Exclusion Criteria:  Patients who experienced acute infections before the procedure. There are other heart defects that require surgery. There is a hereditary, genetic disorder, syndrome or other chronic disease. - HealthyVolunteers: No - Gender: All - MinimumAge: 6 Months - MaximumAge: 18 Years - StdAgeList: Child, Adult